眼科治療の世界市場2019-2023

◆英語タイトル:Global Ophthalmology Therapeutics Market 2019-2023
◆商品コード:IRTNTR31056
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年3月27日
◆ページ数:133
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、眼科治療の世界市場について調査・分析し、市場概要、市場環境、眼科治療市場規模、製品別(網膜障害治療、緑内障治療、眼球乾燥症候群治療、眼感染症及び炎症治療、その他治療)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・眼科治療の世界市場概要
・眼科治療の世界市場環境
・眼科治療の世界市場動向
・眼科治療の世界市場規模
・眼科治療の世界市場:業界構造分析
・眼科治療の世界市場:製品別(網膜障害治療、緑内障治療、眼球乾燥症候群治療、眼感染症及び炎症治療、その他治療)
・眼科治療の世界市場:地域別市場規模・分析
・眼科治療の北米市場規模・予測
・眼科治療のヨーロッパ・中東・アフリカ市場規模・予測
・眼科治療のアジア太平洋市場規模・予測
・眼科治療の主要国分析
・眼科治療の世界市場:意思決定フレームワーク
・眼科治療の世界市場:成長要因、課題
・眼科治療の世界市場:競争環境
・眼科治療の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About this market
The new drug approvals and strong drug pipeline will trigger the ophthalmology therapeutics market growth in the forthcoming years. Top players in the market are focusing on the development of disease-modifying drugs for treating the rising incidences of eye diseases. Furthermore, several market players are focusing on achieving new drug approvals and gene therapy approvals for treating the eye diseases, thus, contributing significantly to the market growth. Technavio’s analysts have predicted that the ophthalmology therapeutics market will register a CAGR of nearly 6% by 2023.
Market Overview
New drug approvals and strong drug pipeline
One of the growth drivers of the global ophthalmology therapeutics market is new drug approvals and strong drug pipeline. The increasing incidence of eye disease is encouraging the top players to focus on the development of disease-modifying drugs to treat these diseases, which will drive the growth of the market during the forecast period.
High cost of treatment
One of the challenges in the growth of the global ophthalmology therapeutics market is the high cost of treatment. The high cost involved in treating various eye diseases can hamper the growth of the market.
For the detailed list of factors that will drive and challenge the growth of the ophthalmology therapeutics market during 019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several market players. Companies are focusing on developing innovative treatments for glaucoma and other eye conditions. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Retinal disorder therapeutics – Market size and forecast 2018-2023
• Glaucoma therapeutics – Market size and forecast 2018-2023
• Dry eye syndrome therapeutics – Market size and forecast 2018-2023
• Eye infections and inflammation therapeutics – Market size
• and forecast 2018-2023
• Other therapeutics – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Market trends
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Regeneron Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Product – Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Retinal disorder therapeutics – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Retinal disorder therapeutics – Year-over-year growth 2019-2023 (%)
Exhibit 21: Glaucoma therapeutics – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Glaucoma therapeutics – Year-over-year growth 2019-2023 (%)
Exhibit 23: Dry eye syndrome therapeutics – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Dry eye syndrome therapeutics – Year-over-year growth 2019-2023 (%)
Exhibit 25: Eye infections and inflammation therapeutics – Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Eye infections and inflammation therapeutics – Year-over-year growth 2019-2023 (%)
Exhibit 27: Other therapeutics – Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Other therapeutics – Year-over-year growth 2019-2023 (%)
Exhibit 29: Market opportunity by product
Exhibit 30: Customer landscape
Exhibit 31: Market share by geography 2018-2023 (%)
Exhibit 32: Geographic comparison
Exhibit 33: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: North America – Year-over-year growth 2019-2023 (%)
Exhibit 35: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 37: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Late-stage pipeline drugs
Exhibit 44: Patent expiry
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Mergers and acquisitions in 2017 and 2018
Exhibit 47: Gene therapies under development
Exhibit 48: Vendor landscape
Exhibit 49: Landscape disruption
Exhibit 50: Vendors covered
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: ALLERGAN – Vendor overview
Exhibit 54: ALLERGAN – Business segments
Exhibit 55: ALLERGAN – Organizational developments
Exhibit 56: ALLERGAN – Geographic focus
Exhibit 57: ALLERGAN – Segment focus
Exhibit 58: ALLERGAN – Key offerings
Exhibit 59: F. Hoffmann-La Roche Ltd – Vendor overview
Exhibit 60: F. Hoffmann-La Roche Ltd – Business segments
Exhibit 61: F. Hoffmann-La Roche Ltd – Organizational developments
Exhibit 62: F. Hoffmann-La Roche Ltd – Geographic focus
Exhibit 63: F. Hoffmann-La Roche Ltd – Segment focus
Exhibit 64: F. Hoffmann-La Roche Ltd – Key offerings
Exhibit 65: Novartis AG – Vendor overview
Exhibit 66: Novartis AG – Business segments
Exhibit 67: Novartis AG – Organizational developments
Exhibit 68: Novartis AG – Geographic focus
Exhibit 69: Novartis AG – Segment focus
Exhibit 70: Novartis AG – Key offerings
Exhibit 71: Regeneron Pharmaceuticals, Inc. – Vendor overview
Exhibit 72: Regeneron Pharmaceuticals, Inc. – Business segments
Exhibit 73: Regeneron Pharmaceuticals, Inc. – Organizational developments
Exhibit 74: Regeneron Pharmaceuticals, Inc. – Key offerings
Exhibit 75: Santen Pharmaceutical Co., Ltd. – Vendor overview
Exhibit 76: Santen Pharmaceutical Co., Ltd. – Business segments
Exhibit 77: Santen Pharmaceutical Co., Ltd. – Organizational developments
Exhibit 78: Santen Pharmaceutical Co., Ltd. – Geographic focus
Exhibit 79: Santen Pharmaceutical Co., Ltd. – Key offerings
Exhibit 80: Validation techniques employed for market sizing



【掲載企業】

ALLERGAN,, F. Hoffmann-La Roche Ltd, Novartis AG, Regeneron Pharmaceuticals Inc, Santen Pharmaceutical Co., Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[眼科治療の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆